Safety and efficacy of oral anticoagulants in extreme weights

The 2021 International Society on Thrombosis and Haemostasis' (ISTH) recommends standard doses of apixaban and rivaroxaban regardless of high body mass index (BMI) and weight, but had not compare DOACs head-to-head in obesity or address underweight patients.

Source: Thrombosis Research - September 11, 2023 Category: Hematology Authors: J. Chin-Hon, L. Davenport, J. Huang, M. Akerman, A. Hindenburg Tags: Full Length Article Source Type: research